Antoine Vuillemin-Thiery
Besancon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 124 publications
Real-word evidence in anti-VEGF naive patients treated with pazopanib for metastatic renal cell carcinoma (mRCC), the APOLON Study.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene Alterations.
Journal: JCO precision oncology
Published: August 07, 2025
rechARge: a randomized phase III trial of the androgen receptor ligand-directed degrader, BMS-986365, vs investigator's choice in patients with mCRPC.
Journal: Future oncology (London, England)
Published: June 02, 2025
Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma.
Journal: Nature medicine
Published: April 19, 2025
Nivolumab in Metastatic Clear-cell Renal Cell Carcinoma: An Integrative Biomarker Analysis from the NIVOREN GETUG-AFU 26 Phase 2 Study.
Journal: European urology
Published: March 24, 2025
High-risk non-muscle invasive bladder cancer: Outcomes of patients who cannot benefit from standard of care.
Journal: The French journal of urology
Published: July 17, 2024
Pain and Health-related Quality of Life with Biweekly Versus Triweekly Cabazitaxel Schedule in Older Men with Metastatic Castration-resistant Prostate Cancer in the Multicenter, Randomized CABASTY Trial.
Journal: European urology oncology
Published: April 12, 2024
Nivolumab in patients with advanced renal cell carcinoma in France: interim results of the observational, real-world WITNESS study.
Journal: ESMO open
Published: January 31, 2024
Safety and efficacy of nivolumab in elderly patients with metastatic clear cell renal cell carcinoma: Analysis of the NIVOREN GETUG-AFU 26 study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 07, 2023
Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 14, 2023
Gastrointestinal metastases in renal cell carcinoma: A retrospective multicenter GETUG (Groupe d'Étude des Tumeurs Uro-Génitales) study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 09, 2023
Biweekly vs Triweekly Cabazitaxel in Older Patients With Metastatic Castration-Resistant Prostate Cancer: The CABASTY Phase 3 Randomized Clinical Trial.
Journal: JAMA oncology
Published: October 26, 2023
Last Updated: 09/26/2026